Dataset Information

Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD.

ABSTRACT: Infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD) has been recently linked to biallelic mutation of the peptidyl-tRNA hydrolase 2 gene PTRH2. Two index patients with IMNEPD in the original report had multiple neurological symptoms such as postnatal microcephaly, intellectual disability, developmental delay, sensorineural deafness, cerebellar atrophy, ataxia, and peripheral neuropathy. In addition, distal muscle weakness and abnormalities of thyroid, pancreas, and liver were found. Here, we report five further IMNEPD patients with a different homozygous PTRH2 mutation, broaden the phenotypic spectrum of the disease and differentiate common symptoms and interindividual variability in IMNEPD associated with a unique mutation. We thereby hope to better define IMNEPD and promote recognition and diagnosis of this novel disease entity.

SUBMITTER: Picker-Minh S

PROVIDER: S-EPMC4850685 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD.

Picker-Minh Sylvie S Mignot Cyril C Doummar Diane D Hashem Mais M Faqeih Eissa E Josset Patrice P Dubern Béatrice B Alkuraya Fowzan S FS Kraemer Nadine N Kaindl Angela M AM

Orphanet journal of rare diseases 20160429 1

Infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD) has been recently linked to biallelic mutation of the peptidyl-tRNA hydrolase 2 gene PTRH2. Two index patients with IMNEPD in the original report had multiple neurological symptoms such as postnatal microcephaly, intellectual disability, developmental delay, sensorineural deafness, cerebellar atrophy, ataxia, and peripheral neuropathy. In addition, distal muscle weakness and abnormalities of thyroid, pancreas, and ...[more]

PMID: 27129381

Dataset Information

Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD.

Publications

Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

A Novel PTRH2 Gene Mutation Causing Infantile-onset Multisystem Neurologic, Endocrine, and Pancreatic Disease in a Bahraini Patient.
| S-EPMC10951560 | biostudies-literature

Novel PTRH2 gene variant causing IMNEPD (infantile-onset multisystem neurologic, endocrine, and pancreatic disease) in 2 Saudi siblings.
| S-EPMC10167404 | biostudies-literature

Mutations in PTRH2 cause novel infantile-onset multisystem disease with intellectual disability, microcephaly, progressive ataxia, and muscle weakness.
| S-EPMC4284127 | biostudies-literature

GAA deficiency (Pompe Disease) in infantile-onset patients
2012-06-14 | GSE38680 | GEO

Infantile-onset myoclonic developmental and epileptic encephalopathy: A new RARS2 phenotype.
| S-EPMC8886097 | biostudies-literature

Enzyme replacement therapy for infantile-onset Pompe disease.
| S-EPMC6486223 | biostudies-literature

Redefining infantile-onset multisystem phenotypes of coenzyme Q<sub>10</sub>-deficiency in the next-generation sequencing era.
| S-EPMC7791541 | biostudies-literature

c.1437G>A intron 9 substitution on acid α-glucosidase gene associated with classic infantile-onset Pompe disease phenotype.
| S-EPMC4499737 | biostudies-literature

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.
| S-EPMC4178954 | biostudies-literature

Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.
| S-EPMC6642938 | biostudies-literature